Hims & Hers Health, Inc. (HIMS) Q3 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Hims & Hers Health, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:03.536 After the speaker's remarks, there will be a question and answer session. 00:00:03.536 -- 00:00:07.241 If you would like to ask a question during this time, simply press star followed by the 00:00:07.241 -- 00:00:11.508 number one on your telephone keypad. If you would like to withdraw your question, press 00:00:11.508 -- 00:00:16.875 star one again. Thank you. I would now like to turn the call over to Bill Newby, 00:00:16.875 -- 00:00:19.960 head of investor relations. Please go ahead. 00:00:19.960 -- 00:00:23.085 Good afternoon, everyone, and welcome to the Henson Hearst Health third quarter 2025 00:00:23.085 -- 00:00:25.826 earnings call. 00:00:28.988 -- 00:00:31.168 at investors.hems.com. 00:00:31.631 -- 00:00:35.115 On the call with me today is Andrew Dudum, our co-founder and chief executive officer, 00:00:35.115 -- 00:00:38.339 and Yemi Okupe, our chief financial officer. 00:00:38.339 -- 00:00:41.704 Before I hand it over to Andrew, I need to remind you of legal safe harbor and cautionary 00:00:41.704 -- 00:00:46.109 declarations. Certain statements and projections of future results made in this presentation 00:00:46.109 -- 00:00:49.894 constitute forward-looking statements that are based on, among other things, our current 00:00:49.894 -- 00:00:54.479 market, competitors, and regulatory expectations, and are subject to risks and uncertainties 00:00:54.479 -- 00:00:57.997 that could cause actual results to vary materially. 00:00:57.997 -- 00:01:01.861 We take no obligation to update publicly any forward-looking statements after this call, 00:01:01.861 -- 00:01:06.546 whether as a result of new information, future events, changes in assumptions, or otherwise. 00:01:06.546 -- 00:01:10.330 The risks, uncertainties, and other fa...